Old CIC Events
24/11/2021
Defensa de tesis: Diagnóstico de clonalidad de los síndromes linfoproliferativos crónicos de células T y NK
Noemí Muñoz García — Centro de Investigación del Cáncer
18/11/2021
High-risk cutaneous squamous cell carcinoma: our contributions to the current understanding and research priorities
Javier Cañueto Álvarez — Hospital Universitario de Salamanca, IBSAL
18/11/2021
Workshop of RiaBio Ibero-American Network on Artificial Intelligence applied to BioData
- — RiaBio
12/11/2021
TESIS: Systematic analysis of RHO GTPase pathway alterations in cancer
Rubén Caloto, Ph.D. student — Centro de Investigación del Cáncer, laboratorio 2
11/11/2021
Insights into KRAS biology to identify novel therapeutic strategies for cancer
Chiara Ambrogio — Molecular Biotechnology Center (MBC) / University of Torino [Torino, Italy]
04/11/2021
Tumor-specific pathways of therapy resistance in ALK-rearranged lymphoma
Roberto Chiarle — Harvard Medical School [Boston, USA]
29/10/2021
Defensa de tesis: Evaluación preclínica de mecanismos de resistencia a fármacos inmunomoduladores en mieloma múltiple
Pedro Mogollón Arroyo — Centro de Investigación del Cáncer
28/10/2021
Arginine methylation and ubiquitylation crosstalk controls DNA end resection and homologous recombination repair
María Pilar Sánchez-Bailón — Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch [Berlin, Germany]
21/10/2021
Insights into the biological determinants of clonal evolution and therapeutic vulnerabilities of del(11q) chronic lymphocytic leukemia
Miguel Quijada Álamo — Centro de Investigación del Cáncer, CIC-IBMCC
14/10/2021
Evolutionary dynamics of human cancers
Trevor Graham — Cancer Research UK Barts Centre / Queen Mary University of London
07/10/2021
Targeting RAS-PI3K signaling to re-educate the stroma of RAS mutant lung cancers
Esther Castellano — Centro de Investigación del Cáncer, CIC-IBMCC
01/07/2021
Role of RRAS2 as an oncogenic driver
Laura Clavaín — Centro de Investigación del Cáncer (CIC-IBMCC)